Cvisc50
Device Ophthalmology
General payments
$32,024
Research payments
$2,155,872
Through program year 2022, $32,024 in general payments and $2,155,872 in research payments were reported against Cvisc50 (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $459,730 | 58 |
| 2021 | Research | $1,443,110 | 86 |
| 2020 | General | $32,024 | 18 |
| 2020 | Research | $253,032 | 19 |
Breakdown
The top 5 of 14 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
18 general · 163 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.